About Barry Wohl
Barry Wohl is a chief business officer at Apnimed.
Barry Wohl first appears on SEC filings in 2018.
Experience
This experience comes from Barry Wohl's profile and from SEC filings. For roles taken from filings, the years are when the filings name Barry Wohl in the role, so the role may have started earlier or lasted longer.
Apnimed, Inc. Current
Chief Business Officer
2018 – Present · Cambridge, MA
Develops oral medicines for people with sleep apnea and other sleep-related breathing diseases.
MT
Macrolide Pharma (now Zikani Therapeutics)
Senior Director, Alliance Management
2017 – 2018
ST
Symbal Therapeutics
Chief Business Officer
2015 – 2017
IG
IMS Consulting Group
Strategy and Management Consultant
2014 – 2015
BI
Biogen Idec
Corporate Strategy and Portfolio Management
2013
ME
Medtronic
Senior Clinical Research Specialist; R&D Design Engineer
2008 – 2012
Key Colleagues at Startups
The people Barry Wohl works with at each company, as listed on that company's latest Form D.
Apnimed, Inc. · Form D, Mar 27, 2026
LM
Lawrence Miller
Executive officer and director
Paul Fonteyne
Director
DM
Dennis Molnar
Executive officer
JA
Joseph Avellone
Director
FB
Francois Beaubien
Director
Chris Dimitropoulos
Director
KL
Kevin Lind
Chief Executive Officer and director
IC
Isaac Cheng
Director
GS
Gary Sender
Director
RB
Ramzi Benamar
Chief Financial Officer